Valuation: Senores Pharmaceuticals Limited

Market Cap 62.26B 649M 570M 539M 489M 919M 924M 6.46B 2.49B 31.77B 2.43B 2.38B 102B P/E 2027 *
39.4x
P/E 2028 * 27.2x
Enterprise Value 62.26B 649M 570M 539M 489M 919M 924M 6.46B 2.49B 31.77B 2.43B 2.38B 102B EV / Sales 2027 *
6.81x
EV / Sales 2028 * 5.24x
Free-Float
45.07%
Yield 2027 *
0.56%
Yield 2028 * 0.85%
1 day-0.25%
1 week-3.62%
Current month-5.65%
1 month-8.33%
3 months+6.47%
6 months+71.55%
Current year+64.41%
1 week 1,336.3
Extreme 1336.3
1,417.9
1 month 1,336.3
Extreme 1336.3
1,532
Current year 706
Extreme 706
1,599
1 year 662.45
Extreme 662.45
1,599
3 years 435.25
Extreme 435.25
1,599
5 years 435.25
Extreme 435.25
1,599
10 years 435.25
Extreme 435.25
1,599
Manager TitleAgeSince
Chief Executive Officer 41 2021-10-14
Director of Finance/CFO 63 2019-12-31
Compliance Officer - 2026-08-25
Director TitleAgeSince
Director/Board Member 41 2021-10-14
Chairman 63 2024-02-09
Director/Board Member 60 2018-05-14
Date Insider Type Main position Quantity % Market Cap. Importance
3/13/25 Buy

Chief Operating Officer

550 0.0012%
2/27/25 Buy

Chief Operating Officer

1,000 0.0022%
2/27/25 Buy

Chief Operating Officer

1,000 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-0.25%-3.62%+100.68% - 651M
+0.11%+2.76%+63.52%+115.51% 1,055B
+0.27%+0.73%+51.33%+73.10% 654B
+0.73%+0.88%+20.70%+73.89% 467B
-1.36%-0.39%+40.20%+41.03% 348B
+1.34%+5.47%+23.37%+31.30% 275B
-0.48%-0.06%+13.56%+12.36% 258B
+0.85%+8.42%+53.17%+55.45% 224B
+0.85%+1.40%+35.78%+101.47% 187B
-0.30%-10.41%-27.62%-61.04% 171B
Average +0.09%+0.46%+37.47%+49.23% 363.9B
Weighted average by Cap. -0.05%+1.32%+40.70%+69.05%

Financials

2027 *2028 *
Net sales 9.14B 95.22M 83.75M 79.19M 71.83M 135M 136M 948M 366M 4.66B 357M 350M 14.99B 11.88B 124M 109M 103M 93.39M 175M 176M 1.23B 476M 6.06B 465M 455M 19.49B
Net income 1.58B 16.47M 14.49M 13.7M 12.43M 23.34M 23.47M 164M 63.35M 807M 61.85M 60.51M 2.59B 2.3B 23.92M 21.04M 19.89M 18.04M 33.89M 34.08M 238M 91.99M 1.17B 89.8M 87.86M 3.76B
Net Debt - -
Logo Senores Pharmaceuticals Limited
Senores Pharmaceuticals Limited is an India-based company. The Company is engaged in the development and manufacturing of a pharmaceutical product. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Acetaminophen + Butalbital Tablet, Candesartan Cilexetil + HCTZ Tablet, Losartan Potassium Tablet, Chlorzoxazone Tablet, Clomiphene Tablet, Deferiprone Tablet, Diltiazem ER Capsule, Enalapril Maleate Tablet, Escitalopram Tablet, Irbesartan Tablet, Olmesartan Medoxomil Tablet and others. It supplies affordable Active Pharmaceutical Ingredients (API) to generic formulations manufacturers. Its product API includes Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Immunosen - Human Normal Immunoglobulin, Senumin - Human Normal Albumin and others.
Employees
368
Date Price Change Volume
26-09-28 ₹1,351.80 -0.25% 122,013
26-09-25 ₹1,355.20 +0.81% 280,996
26-09-24 ₹1,344.30 -2.83% 217,301
26-09-23 ₹1,383.40 +0.25% 134,952
26-09-22 ₹1,379.90 -1.09% 229,036
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,351.80INR
Average target price
1,620.00INR
Spread / Average Target
+19.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SENORES Stock